New research shows people who had COVID-19 at greater risk of developing Type 2 diabetes

People who have had COVID-19 are at a greater risk of developing Type 2 diabetes within a year compared with those who have not been infected, new research published Monday in the journal Lancet Diabetes and Endocrinology shows.
Researchers reviewed the records of more than 181,000 Department of Veterans Affairs patients who were diagnosed with COVID-19 between March 1, 2020, and Sept. 30, 2021, and compared them to records from more than 4.1 million VA patients who were not infected during the same period plus 4.28 million others who received medical care from the VA in 2018 and 2019.
The researchers calculated that individuals diagnosed with COVID-19 were 46 percent more likely to develop Type 2 diabetes for the first time or have a doctor prescribe medicine to control their blood sugar, The Washington Post reports. The elevated risk affected people who had mild or asymptomatic cases, and went up for those who experienced severe COVID symptoms.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
This study does not prove cause and effect, but rather a strong association between COVID-19 and Type 2 diabetes, the Post notes. While VA patients tend to be older, with more men and white people represented, "the risk was evident in all subgroups," said Ziyad Al-Aly of the VA St. Louis Health Care System, who led the review. Because of that, he is telling anyone who has had COVID-19 to "pay attention to your blood sugar." Read more at The Washington Post.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Why is MAGA turning on Amy Coney Barrett?
Today's Big Question She may be the swing vote on Trump cases
By Joel Mathis, The Week US Published
-
Gavin Newsom's podcast debut is not going over well with some liberals
IN THE SPOTLIGHT The first episode of the California Governor and potential presidential candidate's 'This is Gavin Newsom' featured cozy conversation with far-right operative Charlie Kirk and a surprisingly conservative stance on transgender athletes
By Rafi Schwartz, The Week US Published
-
'Extremists still find plenty of digital spaces'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published